Literature DB >> 6587340

Differentiation of myoblast cell lines and biological methylation: 3-deazaadenosine stimulates formation of multinucleated myofibers.

S Scarpa, R Strom, A Bozzi, R R Aksamit, P S Backlund, J Chen, G L Cantoni.   

Abstract

Treatment of myoblast cell lines with 3-deazaadenosine stimulates differentiation into myofibers. Myoblast clone L5/ 3B5 , which does not form myofibers after 6 days in fusion medium, was stimulated to form myofibers after 5 days of culture in fusion medium containing 50 microM 3-deazaadenosine. Myoblast clone L5/ 3C4 , which normally begins to form myofibers after 4 days in fusion medium, was stimulated by 50 microM 3-deazaadenosine to form myofibers after 3 days in culture and the extent of fusion was also increased. In the presence of 100 microM homocysteine thiolactone, the concentration of 3-deazaadenosine that stimulated maximal fusion was reduced by a factor of 10, from 50 microM to 5 microM 3-deazaadenosine. Stimulation of myofiber formation by 3-deazaadenosine suggests a requirement for one or more methylation reactions in myoblast differentiation and the potentiation by homocysteine thiolactone indicates that myofiber formation is specifically stimulated by an intracellular accumulation of 3-deazaadenosylhomocysteine.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6587340      PMCID: PMC345221          DOI: 10.1073/pnas.81.10.3064

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  The enzymatic synthesis of S-adenosyl-L-homocysteine from adenosine and homocysteine.

Authors:  G DE LA HABA; G L CANTONI
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  Acetylcholine receptors of muscle grown in vitro.

Authors:  Z Vogel; A J Sytkowski; M W Nirenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1972-11       Impact factor: 11.205

3.  The in vitro cultivation and differentiation capacities of myogenic cell lines.

Authors:  C Richler; D Yaffe
Journal:  Dev Biol       Date:  1970-09       Impact factor: 3.582

4.  Retention of differentiation potentialities during prolonged cultivation of myogenic cells.

Authors:  D Yaffe
Journal:  Proc Natl Acad Sci U S A       Date:  1968-10       Impact factor: 11.205

Review 5.  DNA methylation and gene activity.

Authors:  W Doerfler
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

6.  Inhibition of IgE-mediated histamine release from rat basophilic leukemia cells and rat mast cells by inhibitors of transmethylation.

Authors:  Y Morita; R P Siraganian
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

7.  Carbocyclic analogue of 3-deazaadenosine: a novel antiviral agent using S-adenosylhomocysteine hydrolase as a pharmacological target.

Authors:  J A Montgomery; S J Clayton; H J Thomas; W M Shannon; G Arnett; A J Bodner; I K Kion; G L Cantoni; P K Chiang
Journal:  J Med Chem       Date:  1982-06       Impact factor: 7.446

8.  Inhibition of chemotaxis by S-3-deazaadenosylhomocysteine in a mouse macrophage cell line.

Authors:  R R Aksamit; W Falk; G L Cantoni
Journal:  J Biol Chem       Date:  1982-01-25       Impact factor: 5.157

9.  5-Azacytidine increases gamma-globin synthesis and reduces the proportion of dense cells in patients with sickle cell anemia.

Authors:  T J Ley; J DeSimone; C T Noguchi; P H Turner; A N Schechter; P Heller; A W Nienhuis
Journal:  Blood       Date:  1983-08       Impact factor: 22.113

10.  Phospholipid methylation and phospholipase A2 activation in cytotoxicity by human natural killer cells.

Authors:  T Hoffman; F Hirata; P Bougnoux; B A Fraser; R H Goldfarb; R B Herberman; J Axelrod
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

View more
  1 in total

1.  Relationship between transient DNA hypomethylation and erythroid differentiation of murine erythroleukemia cells.

Authors:  A Razin; A Levine; T Kafri; S Agostini; T Gomi; G L Cantoni
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.